TearScience, Inc. clinical trials
Acquired by Johnson & Johnson, 2017 · source ↗
The registry lists 6 studies whose lead sponsor is TearScience, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 4, 2018.
Before and after it joined Johnson & Johnson
- First submitted before TearScience, Inc. became part of Johnson & Johnson
- 6
- First submitted after TearScience, Inc. became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- TearScience, Inc.6 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 6 of 6. All Johnson & Johnson studies →
- Treatment of Meibomian Gland Dysfunction Prior to Cataract SurgeryCompletedNCT01808560Not applicable
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson
- Treatment of Meibomian Gland Dysfunction and Dry Eye in Contact Lens WearersCompletedNCT02102464Not applicable
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson
- Diagnostic Evaluation of the Tear FilmCompletedNCT00761917
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson
- Randomized Controlled Trial of Long-term Treatment Effectiveness for Meibomian Gland Dysfunction (MGD) and Dry EyeCompletedNCT01521507Not applicable
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson
- Treatment of Meibomian Gland Dysfunction and Evaporative Dry EyeCompletedNCT00832130Not applicable
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson
- Evaluation of Screening Methods for Treatment of Meibomian Gland DysfunctionCompletedNCT01202747Phase 2/3
Sponsor listed in the registry: TearScience, Inc. · First submitted before TearScience, Inc. became part of Johnson & Johnson